Laurie Gordon

2.4k citations

27 papers · 917 indexed · h-index 17

Co-authors: Chun‐wa Chung Paul Bamborough Rab K. Prinjha Emmanuel H. Demont Antonia J. Lewis Paola Grandi Stephen J. Atkinson David M. Wilson
Topics: Protein Degradation and Inhibitors (13 papers)Multiple Myeloma Research and Treatments (9 papers)Ubiquitin and proteasome pathways (6 papers)
Cited by: Hematology Molecular Biology Organic Chemistry
Journals: Proceedings of the National Academy of Sciences Journal of Medicinal Chemistry European Journal of Pharmacology
Partner nations: United Kingdom United States Germany

In The Last Decade

Laurie Gordon

27 papers receiving 897 citations

Peers

Countries citing papers authored by Laurie Gordon

Since Specialization

Citations

This map shows the geographic impact of Laurie Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Gordon more than expected).

Fields of papers citing papers by Laurie Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Gordon. The network helps show where Laurie Gordon may publish in the future.

Co-authorship network of co-authors of Laurie Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Gordon. A scholar is included among the top collaborators of Laurie Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Gordon. Laurie Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization of a Series of RIPK2 PROTACs 2021 ·Journal of Medicinal Chemistry ·Afjal H. Miah,Ian E. Smith,M.D. Rackham,(unknown),Aditya R. Thawani,Rakesh Nagilla,Pamela A. Haile,Bartholomew J. Votta,Laurie Gordon,Gillian F. Watt,Jane Denyer,(unknown),(unknown),(unknown),(unknown),Ian Churcher,Paul Scott‐Stevens,John D. Harling	49
2	Development of an intracellular quantitative assay to measure compound binding kinetics 2021 ·Cell chemical biology ·(unknown),Daniel A. Thomas,John P. Evans,Matthew Campbell,(unknown),(unknown),Laurie Gordon,Emma J. Jones,Kristin M. Riching,(unknown),(unknown),(unknown),(unknown),Peter D. Craggs	1
3	Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains 2020 ·Journal of Medicinal Chemistry ·(unknown),Paul Bamborough,Chun‐wa Chung,Peter D. Craggs,Laurie Gordon,Paola Grandi,Melanie Leveridge,Matthew Lindon,(unknown),Anne‐Marie Michon,Mária Judit Molnár,Inmaculada Rioja,Peter E. Soden,Natalie H. Theodoulou,Thilo Werner,Nicholas C. O. Tomkinson,Rab K. Prinjha,P. G. Humphreys	27
4	Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions 2019 ·SLAS DISCOVERY ·(unknown),(unknown),(unknown),(unknown),John P. Evans,Antonia J. Lewis,Laurie Gordon,(unknown),(unknown),(unknown),Aaron Cheng,Syandan Chakraborty,Emma J. Jones,Simon C. C. Lucas,(unknown),(unknown),Peter D. Craggs	6
5	Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain 2018 ·Journal of Medicinal Chemistry ·Robert P. Law,Stephen J. Atkinson,Paul Bamborough,Chun‐wa Chung,Emmanuel H. Demont,Laurie Gordon,Matthew Lindon,Rab K. Prinjha,Allan J. B. Watson,David J. Hirst	85
6	Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery 2017 ·Proceedings of the National Academy of Sciences ·André Mateus,Laurie Gordon,Gareth Wayne,Helena Almqvist,Hanna Axelsson,Brinton Seashore‐Ludlow,(unknown),Pär Matsson,Thomas Lundbäck,Andy West,Michael M. Hann,Per Artursson	69
7	Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability 2015 ·SLAS DISCOVERY ·Laurie Gordon,(unknown),Per Artursson,Michael M. Hann,(unknown),André Mateus,Simon A. Readshaw,Klára Valkó,Gareth Wayne,Andy West	43
8	1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain 2014 ·ACS Medicinal Chemistry Letters ·Emmanuel H. Demont,Paul Bamborough,Chun‐wa Chung,Peter D. Craggs,David J. Fallon,Laurie Gordon,Paola Grandi,Clare I. Hobbs,(unknown),Emma J. Jones,Armelle Le Gall,Anne‐Marie Michon,Darren J. Mitchell,Rab K. Prinjha,Andy D. Roberts,Robert J. Sheppard,Robert J. Watson	68
9	The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes 2014 ·MedChemComm ·Stephen J. Atkinson,Peter E. Soden,(unknown),Marcus Bantscheff,Chun‐wa Chung,(unknown),Nicholas Smithers,Rebecca C. Furze,Laurie Gordon,Gerard Drewes,Inmaculada Rioja,Jason Witherington,Nigel J. Parr,Rab K. Prinjha	58
10	Acylglycinamides as inhibitors of glycine transporter type 1 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Roderick A. Porter,Amanda Johns,D. Nash,(unknown),Paul Wyman,Hugh J. Herdon,Simon J. Teague,(unknown),Stefano Fontana,Laurie Gordon	1
11	Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides 2011 ·Journal of Medicinal Chemistry ·Paul Bamborough,Hawa Diallo,(unknown),Laurie Gordon,Antonia J. Lewis,Jonathan T. Seal,David M. Wilson,Michael D. Woodrow,Chun‐wa Chung	139
12	In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE) 2011 ·Neuropharmacology ·(unknown),Vivian J. A. Costantini,Michela Tessari,(unknown),Corrado Carignani,Enzo Valerio,M. H. Selina Mok,Laura Zonzini,(unknown),Massimo Gianotti,Laurie Gordon,Magalie Rocheville,Mauro Corsi,Anna Maria Capelli	25
13	5-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Roberto Arban,Barbara Bertani,(unknown),(unknown),(unknown),(unknown),Massimo Gianotti,Laurie Gordon,(unknown),(unknown),Simone Spada,Angela Worby,Laura Zonzini,(unknown)	7
14	8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors—Part II 2009 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Barbara Bertani,(unknown),(unknown),(unknown),Massimo Gianotti,Laurie Gordon,Matthew Hill,(unknown),Jeannette M. Watson,Laura Zonzini	16
15	Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II 2008 ·Bioorganic & Medicinal Chemistry Letters ·Simon E. Ward,Peter Eddershaw,(unknown),Laurie Gordon,Peter J. Lovell,(unknown),Claire M. Scott,Paul W. Smith,Kevin M. Thewlis,Paul Wyman	7
16	6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Barbara Bertani,(unknown),(unknown),Laurie Gordon,(unknown),Matthew Hill,(unknown),Luigi Stasi,(unknown),(unknown),(unknown),Jeannette M. Watson,Laura Zonzini	23
17	Discovery of Potent, Orally Bioavailable, Selective 5-HT_1A/B/D Receptor Antagonists 2008 ·Journal of Medicinal Chemistry ·Simon E. Ward,Peter Eddershaw,Claire M. Scott,Laurie Gordon,Peter J. Lovell,(unknown),Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Jeannette M. Watson	9
18	SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue 2006 ·European Journal of Pharmacology ·Claire M. Scott,Ellen M. Soffin,Matthew Hill,Peter J. Atkinson,Christopher J. Langmead,Paul Wren,(unknown),Laurie Gordon,Gary Price,(unknown),(unknown),J.J. Hagan,Jeannette M. Watson	13
19	Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade 2006 ·CNS & Neurological Disorders - Drug Targets ·Martyn Wood,Claire M. Scott,(unknown),(unknown),Nisha Patel,(unknown),Angela Worby,Laurie Gordon,(unknown),Graham J. Riley,Ceri H. Davies,Andrew D. Gribble,Declan N.C. Jones	30
20	Use of Norplant® implants in a New York City clinic population 1994 ·Contraception ·Susan I. Gerber,Carolyn Westhoff,(unknown),Laurie Gordon	12

About Laurie Gordon

Laurie Gordon is a scholar working on Hematology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 27 papers that have together received 917 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Multiple Myeloma Research and Treatments (9 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Hematology (243 citations), Molecular Biology (702 citations) and Organic Chemistry (202 citations). Laurie Gordon has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Chun‐wa Chung, Paul Bamborough, Rab K. Prinjha, Emmanuel H. Demont, Antonia J. Lewis, Paola Grandi, Stephen J. Atkinson, David M. Wilson, Jonathan T. Seal and Matthew Lindon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact